Study design

retrospective

Study time

2015.1-2015.12

Country

China

Object

a diagnosis of 5110 resectable PC with an indication for RP, being aged ≥20 years, and histologically confirmed cancer of the prostate in clinical stage T1–4 without distant metastasis (using the staging system of the American Joint Committee on Cancer)

Inclusion criteria

a history of cancer before PC diagnosis (493 patients), unknown clinical or pathological stage (369 patients), unknown D’Amico risk classification (215 patients), unknown Gleason score (178 patients), unknown postoperative Gleason Grade group (99 patients), missing data on preoperative prostate-specific antigen (PSA) concentration (211 patients), clinically node-positive PC (428 patients), unclear margin status (110 patients), and nodenocarcinoma histology (201 patients).

Robots remarks

RARP

Sample size

1407

Topic classification

Comparison of surgical techniques

Keypoint

No significant differences in PSM or biochemical failure-free survival were observed among patients receiving open, laparoscopic, or robotic RP.

Year